Research - Scituate, Massachusetts, United States
Ensovi is developing a proprietary, scalable, in vitro platform that will radically simplify how fine and commodity chemicals are produced. Our team has developed artificial organelles that efficiently produce biochemical energy from light and water, and a continuous, cell-free metabolic system that produces chemicals from carbon dioxide without the overhead and constraints associated with living cells. We are exploring opportunities where we can improve production methods for organic molecules, especially chiral materials. Ensovi's platform advantages include:• Increased yield and purity;• Reduced energy, labor and capital costs;• Alternative to carbohydrate and petroleum feedstocks;• Negative CO2 emissions and reduced waste; and,• Modular scaling and integration with existing plant infrastructure.